The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Tibsovo-Global Market Insights and Sales Trends 2024
Synopsis
Tibsovo is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer.
The global Tibsovo market size is expected to reach US$ 238.5 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Tibsovo in various end use industries. The expanding demands from the Hospital and Pharmacy, are propelling Tibsovo market. 60 Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 30 Tablets segment is estimated at % CAGR for the next seven-year period.
Ivosidenib's market driver is its efficacy in treating relapsed or refractory acute myeloid leukemia (AML) with IDH1 mutations. It inhibits the mutated IDH1 enzyme, leading to remission. The niche target population and limited treatment options contribute to its growth. However, challenges include potential side effects, the need for genetic testing to identify eligible patients, and competition from other AML therapies. Despite challenges, Ivosidenib's promising results and ongoing research in AML with IDH1 mutations present opportunities for market expansion.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tibsovo, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tibsovo market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tibsovo market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tibsovo sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tibsovo covered in this report include Servier Pharmaceuticals. etc.
The global Tibsovo market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Servier Pharmaceuticals
Global Tibsovo market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tibsovo market, Segment by Type:
60 Tablets
30 Tablets
Global Tibsovo market, by Application
Hospital
Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Tibsovo manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Tibsovo in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Tibsovo is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer.
The global Tibsovo market size is expected to reach US$ 238.5 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Tibsovo in various end use industries. The expanding demands from the Hospital and Pharmacy, are propelling Tibsovo market. 60 Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 30 Tablets segment is estimated at % CAGR for the next seven-year period.
Ivosidenib's market driver is its efficacy in treating relapsed or refractory acute myeloid leukemia (AML) with IDH1 mutations. It inhibits the mutated IDH1 enzyme, leading to remission. The niche target population and limited treatment options contribute to its growth. However, challenges include potential side effects, the need for genetic testing to identify eligible patients, and competition from other AML therapies. Despite challenges, Ivosidenib's promising results and ongoing research in AML with IDH1 mutations present opportunities for market expansion.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tibsovo, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tibsovo market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tibsovo market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tibsovo sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tibsovo covered in this report include Servier Pharmaceuticals. etc.
The global Tibsovo market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Servier Pharmaceuticals
Global Tibsovo market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tibsovo market, Segment by Type:
60 Tablets
30 Tablets
Global Tibsovo market, by Application
Hospital
Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Tibsovo manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Tibsovo in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Tibsovo Market Overview
1.1 Tibsovo Product Overview
1.2 Tibsovo Market Segment by Type
1.2.1 60 Tablets
1.2.2 30 Tablets
1.3 Global Tibsovo Market Size by Type
1.3.1 Global Tibsovo Market Size Overview by Type (2018-2029)
1.3.2 Global Tibsovo Historic Market Size Review by Type (2018-2023)
1.3.3 Global Tibsovo Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tibsovo Sales Breakdown by Type (2018-2023)
1.4.2 Europe Tibsovo Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Tibsovo Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Tibsovo Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Tibsovo Sales Breakdown by Type (2018-2023)
2 Global Tibsovo Market Competition by Company
2.1 Global Top Players by Tibsovo Sales (2018-2023)
2.2 Global Top Players by Tibsovo Revenue (2018-2023)
2.3 Global Top Players by Tibsovo Price (2018-2023)
2.4 Global Top Manufacturers Tibsovo Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tibsovo Market Competitive Situation and Trends
2.5.1 Tibsovo Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Tibsovo Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tibsovo as of 2022)
2.7 Date of Key Manufacturers Enter into Tibsovo Market
2.8 Key Manufacturers Tibsovo Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tibsovo Status and Outlook by Region
3.1 Global Tibsovo Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Tibsovo Historic Market Size by Region
3.2.1 Global Tibsovo Sales in Volume by Region (2018-2023)
3.2.2 Global Tibsovo Sales in Value by Region (2018-2023)
3.2.3 Global Tibsovo Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Tibsovo Forecasted Market Size by Region
3.3.1 Global Tibsovo Sales in Volume by Region (2024-2029)
3.3.2 Global Tibsovo Sales in Value by Region (2024-2029)
3.3.3 Global Tibsovo Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Tibsovo by Application
4.1 Tibsovo Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global Tibsovo Market Size by Application
4.2.1 Global Tibsovo Market Size Overview by Application (2018-2029)
4.2.2 Global Tibsovo Historic Market Size Review by Application (2018-2023)
4.2.3 Global Tibsovo Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tibsovo Sales Breakdown by Application (2018-2023)
4.3.2 Europe Tibsovo Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Tibsovo Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Tibsovo Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Tibsovo Sales Breakdown by Application (2018-2023)
5 North America Tibsovo by Country
5.1 North America Tibsovo Historic Market Size by Country
5.1.1 North America Tibsovo Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Tibsovo Sales in Volume by Country (2018-2023)
5.1.3 North America Tibsovo Sales in Value by Country (2018-2023)
5.2 North America Tibsovo Forecasted Market Size by Country
5.2.1 North America Tibsovo Sales in Volume by Country (2024-2029)
5.2.2 North America Tibsovo Sales in Value by Country (2024-2029)
6 Europe Tibsovo by Country
6.1 Europe Tibsovo Historic Market Size by Country
6.1.1 Europe Tibsovo Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Tibsovo Sales in Volume by Country (2018-2023)
6.1.3 Europe Tibsovo Sales in Value by Country (2018-2023)
6.2 Europe Tibsovo Forecasted Market Size by Country
6.2.1 Europe Tibsovo Sales in Volume by Country (2024-2029)
6.2.2 Europe Tibsovo Sales in Value by Country (2024-2029)
7 Asia-Pacific Tibsovo by Region
7.1 Asia-Pacific Tibsovo Historic Market Size by Region
7.1.1 Asia-Pacific Tibsovo Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Tibsovo Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Tibsovo Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Tibsovo Forecasted Market Size by Region
7.2.1 Asia-Pacific Tibsovo Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Tibsovo Sales in Value by Region (2024-2029)
8 Latin America Tibsovo by Country
8.1 Latin America Tibsovo Historic Market Size by Country
8.1.1 Latin America Tibsovo Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Tibsovo Sales in Volume by Country (2018-2023)
8.1.3 Latin America Tibsovo Sales in Value by Country (2018-2023)
8.2 Latin America Tibsovo Forecasted Market Size by Country
8.2.1 Latin America Tibsovo Sales in Volume by Country (2024-2029)
8.2.2 Latin America Tibsovo Sales in Value by Country (2024-2029)
9 Middle East and Africa Tibsovo by Country
9.1 Middle East and Africa Tibsovo Historic Market Size by Country
9.1.1 Middle East and Africa Tibsovo Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Tibsovo Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Tibsovo Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Tibsovo Forecasted Market Size by Country
9.2.1 Middle East and Africa Tibsovo Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Tibsovo Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Servier Pharmaceuticals
10.1.1 Servier Pharmaceuticals Company Information
10.1.2 Servier Pharmaceuticals Introduction and Business Overview
10.1.3 Servier Pharmaceuticals Tibsovo Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Servier Pharmaceuticals Tibsovo Products Offered
10.1.5 Servier Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tibsovo Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tibsovo Industrial Chain Analysis
11.4 Tibsovo Market Dynamics
11.4.1 Tibsovo Industry Trends
11.4.2 Tibsovo Market Drivers
11.4.3 Tibsovo Market Challenges
11.4.4 Tibsovo Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tibsovo Distributors
12.3 Tibsovo Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
